Sahlgrenska Cardiomyopathy Project
- Conditions
- MyocarditisDilated CardiomyopathiesRestrictive CardiomyopathySarcoidosis With MyocarditisGiant Cell MyocarditisArrhythmogenic Right Ventricular CardiomyopathyAmyloidosis; Heart (Manifestation)Hypertrophic Cardiomyopathy
- Registration Number
- NCT03527342
- Lead Sponsor
- Göteborg University
- Brief Summary
This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal.
Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as:
1. resource for diagnostic and therapeutic trials
2. common biomaterial bank
3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 3000
- Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart
- Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose
- patients < 18 years
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to disease progression 2018-2028
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Göteborg University, Sahlgrenska Universitetssjukhuset
🇸🇪Göteborg, Sweden